# The Eplontersen Pregnancy and Lactation Outcomes Study

> **NCT07205666** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 10 (estimated)

## Conditions studied

- Transthyretin Amyloidosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07205666
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-30
- **Primary completion:** 2035-12-30
- **Final completion:** 2035-12-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07205666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07205666, "The Eplontersen Pregnancy and Lactation Outcomes Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07205666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*